Plain-English translation of NCT05850130 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study tests whether acupuncture can help reduce nerve pain caused by oxaliplatin, a chemotherapy drug used to treat cancers of the digestive system. Some patients with these cancers experience painful tingling or numbness in their hands and feet after finishing treatment with this medication. Researchers want to see if acupuncture—a traditional treatment where thin needles are placed at specific points on the body—can ease this pain.
Nerve pain from chemotherapy can be serious and long-lasting, affecting quality of life even after cancer treatment ends. There are limited treatment options for this side effect, so doctors are exploring whether this treatment might be a helpful, safe way to reduce that pain.
You likely qualify if…
You likely don't qualify if…
If you join, you will be randomly assigned to one of two groups. One group will receive acupuncture once a week for 6 weeks; the other group will not receive acupuncture during this first phase. After 6 weeks, your nerve pain will be assessed. If your pain score is high, you will be offered acupuncture treatment. If it's low, you may choose whether to receive additional acupuncture. The entire study lasts about 12 weeks, and all acupuncture will be performed by a physician trained in this technique.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France